DI
BMY icon

Disciplined Investments’s Bristol-Myers Squibb BMY Stock Holding History

Disciplined Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-931
Closed -$59.5K – 288
2023
Q2 		$59.5K Buy
931
+5
+0.5% +$335 0.03% 188
2023
Q1 		$64.2K Sell
926
-31
-3% -$2.19K 0.03% 205
2022
Q4 		$68.9K Buy
957
+43
+5% +$3.24K 0.03% 182
2022
Q3 		$65K Sell
914
-38
-4% -$2.76K 0.03% 200
2022
Q2 		$73K Buy
952
+38
+4% +$2.89K 0.03% 189
2022
Q1 		$67K Buy
914
+291
+47% +$19.5K 0.03% 196
2021
Q4 		$39K Buy
623
+300
+93% +$17.6K 0.02% 232
2021
Q3 		$19K Buy
323
+100
+45% +$6.59K 0.01% 276
2021
Q2 		$15K Buy
+223
New +$14.5K 0.01% 281
2020
Q4 		– Sell
-346
Closed -$21K – 323
2020
Q3 		$21K Sell
346
-34
-9% -$2.05K 0.02% 210
2020
Q2 		$22K Hold
380
– – 0.02% 216
2020
Q1 		$21K Sell
380
-42
-10% -$2.57K 0.02% 210
2019
Q4 		$27K Buy
+422
New +$24.2K 0.02% 211

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Disciplined Investments's BMY Position: Q3 2023 in Review

Disciplined Investments sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 931 shares — an estimated $59.5K sold.

Disciplined Investments first reported a position in BMY in Q4 2019 and held it in 13 quarters. The position peaked at $73K in Q2 2022. 2,389 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Disciplined Investments reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 931 Bristol-Myers Squibb shares in Q3 2023, an estimated $59.5K.
  • Disciplined Investments first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 13 quarters.
  • Disciplined Investments's Bristol-Myers Squibb position peaked at $73K in Q2 2022.
  • 2,389 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.